CGON
Price
$53.51
Change
-$2.00 (-3.60%)
Updated
Jan 15, 11:17 AM (EDT)
Capitalization
4.48B
71 days until earnings call
Intraday BUY SELL Signals
SPRY
Price
$11.40
Change
-$0.39 (-3.31%)
Updated
Jan 15, 12:10 PM (EDT)
Capitalization
1.16B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs SPRY

Header iconCGON vs SPRY Comparison
Open Charts CGON vs SPRYBanner chart's image
CG Oncology
Price$53.51
Change-$2.00 (-3.60%)
Volume$200
Capitalization4.48B
ARS Pharmaceuticals
Price$11.40
Change-$0.39 (-3.31%)
Volume$500
Capitalization1.16B
CGON vs SPRY Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. SPRY commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CGON: $55.51 vs. SPRY: $11.79)
Brand notoriety: CGON and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 105% vs. SPRY: 65%
Market capitalization -- CGON: $4.48B vs. SPRY: $1.16B
CGON [@Biotechnology] is valued at $4.48B. SPRY’s [@Biotechnology] market capitalization is $1.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, CGON is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 6 bullish, 4 bearish.
  • SPRY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CGON is a better buy in the short-term than SPRY.

Price Growth

CGON (@Biotechnology) experienced а +30.77% price change this week, while SPRY (@Biotechnology) price change was +6.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CGON is expected to report earnings on Mar 27, 2026.

SPRY is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($4.48B) has a higher market cap than SPRY($1.16B). CGON YTD gains are higher at: 33.695 vs. SPRY (1.202). SPRY has higher annual earnings (EBITDA): -90.79M vs. CGON (-179.53M). CGON has more cash in the bank: 680M vs. SPRY (288M). CGON has less debt than SPRY: CGON (7.24M) vs SPRY (97.8M). SPRY has higher revenues than CGON: SPRY (143M) vs CGON (2.17M).
CGONSPRYCGON / SPRY
Capitalization4.48B1.16B385%
EBITDA-179.53M-90.79M198%
Gain YTD33.6951.2022,804%
P/E RatioN/A151.25-
Revenue2.17M143M2%
Total Cash680M288M236%
Total Debt7.24M97.8M7%
TECHNICAL ANALYSIS
Technical Analysis
CGONSPRY
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 25 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
SPRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNOIX37.310.23
+0.62%
Easterly Snow Long/Short Opportunity I
CDDRX38.100.12
+0.32%
Columbia Dividend Income Inst2
HNCSX22.87-0.14
-0.61%
Hartford International Growth R4
SMMSX28.38-0.44
-1.53%
Invesco Summit S
KLCIX16.72-0.26
-1.53%
Federated Hermes Kaufmann Large Cap IS

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with RVMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+5.57%
RVMD - CGON
54%
Loosely correlated
+1.06%
NUVL - CGON
53%
Loosely correlated
+6.59%
SYRE - CGON
53%
Loosely correlated
+5.17%
IDYA - CGON
52%
Loosely correlated
+5.53%
XNCR - CGON
51%
Loosely correlated
+3.66%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+4.24%
LPCN - SPRY
63%
Loosely correlated
+5.06%
KROS - SPRY
34%
Loosely correlated
+0.15%
REPL - SPRY
31%
Poorly correlated
-4.10%
CGON - SPRY
30%
Poorly correlated
+5.57%
AVBP - SPRY
29%
Poorly correlated
+2.28%
More